IDSA GUIDELINES Bundle

Pediatric Community-Acquired Pneumonia (IDSA Bundle)

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/222759

Contents of this Issue

Navigation

Page 1 of 25

Key Points For definitions of the abbreviations in green see Table 9. ÎÎPneumonia is the single greatest cause of death in children worldwide. Each year, more than 2 million children younger than 5 years die from pneumonia, representing approximately 20% of all deaths in children within this age group. ÎÎIn the developed world, the annual incidence of pneumonia is approximately 3-4 cases per 100 children younger than 5 years. Incidence varies inversely with age. ÎÎVaccines have dramatically decreased the incidence of infections, including community-aquired pneumonia (CAP). ÎÎPathogens responsible for "atypical pneumonia" have been identified in 3% to 23% of children studied, with Mycoplasma pneumoniae more often identified in older children. ÎÎViral etiologies of CAP have been documented in up to 80% of children younger than 2 years. In contrast, investigations of older children, 10-16 years, who had both clinical and radiographic evidence of pneumonia, documented a much lower percentage of viral pathogens. ÎÎRespiratory syncytial virus (RSV) is consistently the most frequently detected virus, representing up to 40% of identified pathogens in those younger than 2 years, but rarely identified in older children with CAP. Less frequently detected are adenoviruses, bocavirus, human metapneumovirus, influenza A and B viruses, parainfluenza viruses, coronaviruses and rhinovirus. Note: 2% to 33% of children hospitalized with CAP are simultaneously infected by 2 or more viruses.

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle - Pediatric Community-Acquired Pneumonia (IDSA Bundle)